HFpEF is most common among older adults and women. This article discusses the symptoms, causes, diagnosis, and treatment of heart failure with preserved ejection fraction. If you have HFpEF, your ...

A recent study found that tirzepatide, the active ingredient in Zepbound and Mounjaro, could reduce the risk of ...

Mavacamten, a drug initially developed to treat hypertrophic cardiomyopathy, has shown signs of reducing heart stress in ...

Catheter ablation is associated with significant reductions in AF symptoms, AF-related hospitalization, and HF symptoms across HF subtypes.

After 19 weeks on daily oral HU6 treatment, people shed on average 2.9 kg (~6.3 lb) or 2.7% of their starting body weight relative to placebo, both significant changes supporting some efficacy of the ...

Objective Iron deficiency (ID) has an established impact on outcomes in patients with heart failure with reduced ejection fraction; however, there is a lack of conclusive evidence in patients with ...

Lilly also measured how participants’ heart failure symptoms improved using the Kansas City Cardiomyopathy Questionnaire ...

Introduction: Heart failure with preserved ejection fraction (HFpEF) is a heterogenous syndrome with multiple co-morbidities and has limited therapeutic options. To better understand the underlying ...

The positive opinion is based on the results from the STEP HFpEF and STEP HFpEF-DM trials. Novo Nordisk will resubmit to the FDA in 2025 to include data from the STEP HFpEF trials in the Wegovy ...